---
created: 2025-04-13
updated: 2025-04-13T10:53
id: sdr?6WfmXH
specialty: obgyn
specialty_id: 189
tags:
  - source/ak-original-decks::step-1::zanki-step-decks::zanki-reproductive::reproductive-pathology
  - source/ak-step1-v11::!flag-these-cards::sketchypathadds
  - "source/ak-step1-v11:": 
  - theme/firstaid::15-repro::05-pharm::10-combined-contraception
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::12-reproductive::06-combined-contraception-and-copper-iuds
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::18-reproductive::05-progestins
  - "source/ak-step1-v11:": 
  - theme/sketchypath::08-repro-&-gu::01-uterine-&-vulvovaginal-disorders::01-abnormal-uterine-bleeding-(aub)-&-endometriosis
  - source/ak-step1-v11::$ankingupdates::$errata::bonus::jbadd
  - source/ak-step1-v11::^other::^expn::jbadd
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::reproductive::jbadds"
type: flashcard
---

# Question
The risk of endometrial hyperplasia is reduced with use of **OCPs**    *bonus: why?

---

# Answer
due to presence of both progestins and estrogen